Contract W81K0024P0169
Diasorin Inc · Department Of Defense · August 21, 2024
Diasorin Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on August 21, 2024 for $519,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Stillwater, MN. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 31, 2025. If all options are exercised, the contract could reach $2.00 million.
Contract details
- PIID
- W81K0024P0169
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Stillwater, MN
- First action
- August 21, 2024
- Latest action
- December 31, 2025
Description
COST PER TESTS
Modification timeline
-
December 31, 2025Mod P00004$261.5K
-
August 25, 2025Mod P00003EXERCISE OPTION ONE FY26$0
-
August 19, 2025Mod P00002FY25 DEOBLIGATION OF -$25,160.40 MANUAL PR # 0012031741 2) FY25 CREATE NEW CLIN 1001AF TO ADD 26 TESTS FOR AN INCREASE OF $20,891.78 REFERENCE PR # 001230174. C$-4.3K
-
October 29, 2024Mod P00001FY25 FUND VARICELLA-ZOSTER VIRUS (VZV)$261.5K
-
August 21, 2024Base awardREAGENTS AND ANALYZERS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
| Quidelortho Sales Company, Llc | Department Of Defense | December 30, 2025 | $505.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0024P0169?
Contract W81K0024P0169 is a federal contract awarded to Diasorin Inc by Department Of Defense on August 21, 2024 for $519,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 4 times since the base award.
Who won contract W81K0024P0169?
Diasorin Inc won contract W81K0024P0169 from Department Of Defense.
How much is contract W81K0024P0169 worth?
Contract W81K0024P0169 has obligated $519,000 to date, with a total potential value of $2.00 million if all options are exercised.